Management of CMV infections: recommendations from the infectious diseases working party of the EBMT

被引：85

作者：

Ljungman, P ^{[1
]}

Reusser, P ^{[1
]}

de la Camara, R ^{[1
]}

Einsele, H ^{[1
]}

Engelhard, D ^{[1
]}

Ribaud, P ^{[1
]}

Ward, K ^{[1
]}

Cordonnier, C ^{[1
]}

机构：

[1] Huddinge Univ Hosp, Dept Haematol, Stockholm, Sweden

来源：

BONE MARROW TRANSPLANTATION | 2004年 / 33卷 / 11期

关键词：

CMV; stem cell transplantation; PCR; antigenaemia; antiviral drugs;

D O I：

10.1038/sj.bmt.1704505

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

[No abstract available]

引用

页码：1075 / 1081

页数：7

共 60 条

[1]

[Anonymous], 2000, MMWR Recomm Rep, V49, P1

[2] A survey of allogeneic bone marrow transplant programs in the United States regarding cytomegalovirus prophylaxis and pre-emptive therapy [J].

Avery, RK ;

Adal, KA ;

Longworth, DL ;

Bolwell, BJ .

BONE MARROW TRANSPLANTATION, 2000, 26 (07) :763-767

[3]

BASS E, 1993, BONE MARROW TRANSPL, V12, P179

[4]

BOECKH M, 1992, BLOOD, V80, P1358

[5] Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation [J].

Boeckh, M ;

StevensAyers, T ;

Bowden, RA .

JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) :907-912

[6] Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity [J].

Boeckh, M ;

Leisenring, W ;

Riddell, SR ;

Bowden, RA ;

Huang, ML ;

Myerson, D ;

Stevens-Ayers, T ;

Flowers, MED ;

Cunningham, T ;

Corey, L .

BLOOD, 2003, 101 (02) :407-414

[7] Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study [J].

Boeckh, M ;

Gooley, TA ;

Myerson, D ;

Cunningham, T ;

Schoch, G ;

Bowden, RA .

BLOOD, 1996, 88 (10) :4063-4071

[8] Quantitation of cytomegalovirus: Methodologic aspects and clinical applications [J].

Boeckh, M ;

Boivin, G .

CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (03) :533-+

[9] A COMPARISON OF FILTERED LEUKOCYTE-REDUCED AND CYTOMEGALOVIRUS (CMV) SERONEGATIVE BLOOD PRODUCTS FOR THE PREVENTION OF TRANSFUSION-ASSOCIATED CMV INFECTION AFTER MARROW TRANSPLANT [J].

BOWDEN, RA ;

SLICHTER, SJ ;

SAYERS, M ;

WEISDORF, D ;

CAYS, M ;

SCHOCH, G ;

BANAJI, M ;

HAAKE, R ;

WELK, K ;

FISHER, L ;

MCCULLOUGH, J ;

MILLER, W .

BLOOD, 1995, 86 (09) :3598-3603

[10]

BOWDEN RA, 1991, BLOOD, V78, P246

← 1 2 3 4 5 6 →